Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Drug Resistance, Viral"" wg kryterium: Temat


Tytuł:
HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon.
Autorzy:
Nzengui-Nzengui GF; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Mourembou G; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
M'boyis-Kamdem H; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Kombila-Koumavor AC; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Ndjoyi-Mbiguino A; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 14; Vol. 24 (1), pp. 316. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
HIV Infections*/drug therapy
HIV-1*/genetics
Male ; Humans ; Female ; Reverse Transcriptase Inhibitors/therapeutic use ; HIV Protease/genetics ; Gabon ; Anti-Retroviral Agents/therapeutic use ; Protease Inhibitors/therapeutic use ; Mutation ; Drug Resistance, Viral/genetics
Czasopismo naukowe
Tytuł:
HIV-1 Drug Resistance Detected by Next-Generation Sequencing among ART-Naïve Individuals: A Systematic Review and Meta-Analysis.
Autorzy:
Ouyang F; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.
Yuan D; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.
Zhai W; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.
Liu S; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.
Zhou Y; Department of HIV/STD Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Yang H; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing 210009, China.; Jiangsu Health Development Research Center, Nanjing 210029, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Feb 02; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
HIV-1*/genetics
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Seropositivity*
Humans ; Genotype ; Drug Resistance, Viral/genetics ; High-Throughput Nucleotide Sequencing/methods ; Prevalence ; Mutation
Czasopismo naukowe
Tytuł:
Analysis of ART effects and drug resistance in adult HIV/AIDS patients in Meigu County, Liangshan Prefecture, China.
Autorzy:
Yuan L; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Chen K; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Cai Y; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Zhou Z; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Yang J; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Jiqu W; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Zhu Q; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Zhang H; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Niu S; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Sun H; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 01; Vol. 24 (1), pp. 155. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV-1*/genetics
Nucleic Acids*
Adult ; Humans ; Emtricitabine/therapeutic use ; Nevirapine/pharmacology ; Nevirapine/therapeutic use ; Didanosine ; Mutation ; Drug Resistance ; Drug Resistance, Viral/genetics
Czasopismo naukowe
Tytuł:
Prevalence of acquired and transmitted HIV drug resistance in Iran: a systematic review and meta-analysis.
Autorzy:
Mirzaei H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616911320, Iran.
Eybpoosh S; Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.
Mehrabi F; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616911320, Iran.
Shojaei MR; Department of Microbiology and Virology, Kerman University of Medical Science, Kerman, Iran.
Mirzazadeh A; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616911320, Iran.; Department of Epidemiology and Biostatistics, Institute for Global Health Sciences, University of California, San Francisco, USA.
Khezri M; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616911320, Iran.; Department of Epidemiology, New York University School of Global Public Health, New York, NY, USA.
Nasiri N; School of Health, Jiroft University of Medical Sciences, Jiroft, Iran.
Sharifi H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616911320, Iran. .; Affiliate, Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Jan 02; Vol. 24 (1), pp. 29. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
HIV-1*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
Humans ; Iran/epidemiology ; Reverse Transcriptase Inhibitors/therapeutic use ; Prevalence ; Drug Resistance, Viral ; Mutation
Czasopismo naukowe
Tytuł:
Low level of HIV-1C integrase strand transfer inhibitor resistance mutations among recently diagnosed ART-naive Ethiopians.
Autorzy:
Kiros M; Department of Medical Laboratory Science, College of Medicine and Health Sciences, Aksum University, Aksum, Ethiopia. .
Tefera DA; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Andualem H; Department of Medical Laboratory Science, College of Medicine and Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Geteneh A; Department of Medical Laboratory Science, College of Health Sciences, Woldia University, Woldia, Ethiopia.
Tesfaye A; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Woldemichael TS; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Kidane E; The Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Alemayehu DH; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Maier M; Department Virology, Institute Medical Microbiology and Virology, Leipzig University, Leipzig, Germany.
Mihret A; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Abegaz WE; Department of Microbiology, Parasitology, and Immunology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Mulu A; Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Apr 21; Vol. 13 (1), pp. 6546. Date of Electronic Publication: 2023 Apr 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Resistance, Viral*/drug effects
Drug Resistance, Viral*/genetics
HIV Infections*/drug therapy
HIV Infections*/genetics
HIV Infections*/virology
HIV Integrase*/drug effects
HIV Integrase*/genetics
HIV Integrase*/isolation & purification
HIV Integrase Inhibitors*/pharmacology
HIV Integrase Inhibitors*/therapeutic use
HIV-1*/drug effects
HIV-1*/genetics
HIV-1*/isolation & purification
Drug Resistance, Neoplasm*/drug effects
Drug Resistance, Neoplasm*/genetics
Humans ; Cross-Sectional Studies ; Genotype ; HIV Seropositivity/drug therapy ; Mutation
Czasopismo naukowe
Tytuł:
Characterization of Human Immunodeficiency Virus-1 Transmission Clusters and Transmitted Drug-Resistant Mutations in Croatia from 2019 to 2022.
Autorzy:
Planinić A; Department of Immunological and Molecular Diagnostics, University Hospital for Infectious Diseases Dr. Fran Mihaljević, 10000 Zagreb, Croatia.
Begovac J; School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Rokić F; Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Šimičić P; Department of Oncology and Nuclear Medicine, Sestre Milosrdnice University Hospital Center, 10000 Zagreb, Croatia.
Oroz M; Cytogenetic Laboratory, Department of Obstetrics and Gynecology, Clinical Hospital Sveti Duh, 10000 Zagreb, Croatia.
Jakovac K; Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Vugrek O; Ruđer Bošković Institute, 10000 Zagreb, Croatia.
Zidovec-Lepej S; Department of Immunological and Molecular Diagnostics, University Hospital for Infectious Diseases Dr. Fran Mihaljević, 10000 Zagreb, Croatia.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Dec 11; Vol. 15 (12). Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
HIV-1*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
Humans ; Croatia/epidemiology ; Phylogeny ; Genotype ; Drug Resistance, Viral/genetics ; Mutation ; Prevalence
Czasopismo naukowe
Tytuł:
The Discovery of Indole-2-carboxylic Acid Derivatives as Novel HIV-1 Integrase Strand Transfer Inhibitors.
Autorzy:
Wang YC; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.; Center for Tissue Engineering and Stem Cell Research, Key Laboratory of Regenerative Medicine of Guizhou Province, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550004, China.; School of Pharmacy, Guizhou Medical University, Guian New District, Guiyang 550025, China.
Zhang WL; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.; School of Pharmacy, Guizhou Medical University, Guian New District, Guiyang 550025, China.
Zhang RH; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.; Center for Tissue Engineering and Stem Cell Research, Key Laboratory of Regenerative Medicine of Guizhou Province, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550004, China.
Liu CH; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.
Zhao YL; School of Pharmacy, Guizhou Medical University, Guian New District, Guiyang 550025, China.
Yan GY; School of Pharmacy, Xinxiang University, Xinxiang 453000, China.
Liao SG; School of Pharmacy, Guizhou Medical University, Guian New District, Guiyang 550025, China.
Li YJ; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.
Zhou M; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.; School of Pharmacy, Guizhou Medical University, Guian New District, Guiyang 550025, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Dec 08; Vol. 28 (24). Date of Electronic Publication: 2023 Dec 08.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Integrase Inhibitors*/pharmacology
HIV Integrase Inhibitors*/chemistry
HIV-1*
HIV Integrase*/metabolism
HIV Infections*/drug therapy
Humans ; Molecular Docking Simulation ; Indoles/pharmacology ; Indoles/therapeutic use ; Catalytic Domain ; Drug Resistance, Viral ; Mutation
Czasopismo naukowe
Tytuł:
Differences in drug resistance of HIV-1 genotypes in CSF and plasma and analysis of related factors.
Autorzy:
Wang J; Central lab, Chongqing Public Health Medical Center, Chongqing, China.
Li M; Central lab, Chongqing Public Health Medical Center, Chongqing, China.
Li J; Central lab, Chongqing Public Health Medical Center, Chongqing, China.
Deng R; Central lab, Chongqing Public Health Medical Center, Chongqing, China.
Pokaż więcej
Źródło:
Virulence [Virulence] 2023 Dec; Vol. 14 (1), pp. 2171632.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*/genetics
HIV Infections*/drug therapy
Humans ; Quality of Life ; Drug Resistance, Viral/genetics ; Genotype
Czasopismo naukowe
Tytuł:
Prevalence and analysis of acquired and transmitted integrase strand transfer inhibitor-associated HIV-1 drug resistance in Chongqing, China.
Autorzy:
Zhang H; Central Laboratory, Chongqing Public Health Medical Center, Chongqing, China.
Wu P; Department of Tuberculosis, Chongqing Public Health Medical Center, Chongqing, China.
Li J; Central Laboratory, Chongqing Public Health Medical Center, Chongqing, China.
Li M; Central Laboratory, Chongqing Public Health Medical Center, Chongqing, China.
Pokaż więcej
Źródło:
Virulence [Virulence] 2023 Dec; Vol. 14 (1), pp. 2278254. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*/genetics
HIV Integrase Inhibitors*/pharmacology
HIV Integrase Inhibitors*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Integrase*/genetics
HIV Integrase*/pharmacology
Humans ; Prevalence ; Drug Resistance, Viral/genetics ; Mutation ; Genotype ; China/epidemiology
Czasopismo naukowe
Tytuł:
High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam.
Autorzy:
Bwire GM; Laboratory of Clinical and Epidemiological Virology (Rega Institute), Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research Clinical and Epidemiological Virology, Institute for the Future, KU Leuven, Rega-Herestraat 49-Bus 1040, 3000, Leuven, Belgium. .; Department of Pharmaceutical Microbiology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, 65013, Tanzania. .
Aiko BG; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, 65013, Tanzania.; Faculty of Economics and Business, Access to Medicine Research Center, KU Leuven, 3000, Leuven, Belgium.
Mosha IH; Department of Behavioural Sciences, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, 65015, Tanzania.
Kilapilo MS; Department of Pharmaceutical Microbiology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, 65013, Tanzania.
Mangara A; Department of Epidemiology and Biostatistics, School of Public Health and Social Sciences, Dar es Salaam Urban Cohort Study, Dar es Salaam, 65013, Tanzania.
Kazonda P; Department of Epidemiology and Biostatistics, School of Public Health and Social Sciences, Dar es Salaam Urban Cohort Study, Dar es Salaam, 65013, Tanzania.
Swai JP; Department of Business Studies, School of Business, Mzumbe University, Dar es Salaam, 20266, Tanzania.
Swalehe O; Department of Business Studies, School of Business, Mzumbe University, Dar es Salaam, 20266, Tanzania.
Jordan MR; Tufts University School of Medicine, Boston, MA, USA.
Vercauteren J; Laboratory of Clinical and Epidemiological Virology (Rega Institute), Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research Clinical and Epidemiological Virology, Institute for the Future, KU Leuven, Rega-Herestraat 49-Bus 1040, 3000, Leuven, Belgium.
Sando D; Managament and Development for Health, Mwai Kibaki Road, Dar es Salaam, Tanzania.
Temba D; Managament and Development for Health, Mwai Kibaki Road, Dar es Salaam, Tanzania.
Shao A; Managament and Development for Health, Mwai Kibaki Road, Dar es Salaam, Tanzania.
Mauka W; Managament and Development for Health, Mwai Kibaki Road, Dar es Salaam, Tanzania.
Decouttere C; Faculty of Economics and Business, Access to Medicine Research Center, KU Leuven, 3000, Leuven, Belgium.
Vandaele N; Faculty of Economics and Business, Access to Medicine Research Center, KU Leuven, 3000, Leuven, Belgium.
Sangeda RZ; Department of Pharmaceutical Microbiology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, 65013, Tanzania.
Killewo J; Department of Epidemiology and Biostatistics, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, 65015, Tanzania.
Vandamme AM; Laboratory of Clinical and Epidemiological Virology (Rega Institute), Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research Clinical and Epidemiological Virology, Institute for the Future, KU Leuven, Rega-Herestraat 49-Bus 1040, 3000, Leuven, Belgium.; Center for Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 22; Vol. 13 (1), pp. 20493. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV-1*/genetics
HIV Seropositivity*/drug therapy
Humans ; Adult ; Male ; Female ; Child ; Tanzania ; Cross-Sectional Studies ; Drug Resistance, Viral/genetics ; Reverse Transcriptase Inhibitors/pharmacology ; Reverse Transcriptase Inhibitors/therapeutic use ; Mutation ; Integrases/genetics ; Viral Load
Czasopismo naukowe
Tytuł:
Trends in HIV-1 pretreatment drug resistance and HIV-1 variant dynamics among antiretroviral therapy-naive Ethiopians from 2003 to 2018: a pooled sequence analysis.
Autorzy:
Kiros M; Department of Medical Laboratory Science, CollegeofMedicineandHealth Sciences, Aksum University, Aksum, Ethiopia. .
Biset S; Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Gebremariam B; Department of Medical Laboratory Science, CollegeofMedicineandHealth Sciences, Aksum University, Aksum, Ethiopia.
Yalew GT; Department of Medical Laboratory Science, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia.
Abegaz WE; Department of Microbiology, Parasitology, and Immunology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Geteneh A; Department of Medical Laboratory Sciences, College of Health Sciences, Woldia University, Woldia, Ethiopia.
Pokaż więcej
Źródło:
Virology journal [Virol J] 2023 Oct 25; Vol. 20 (1), pp. 243. Date of Electronic Publication: 2023 Oct 25.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
HIV-1*/genetics
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Seropositivity*/drug therapy
Humans ; Reverse Transcriptase Inhibitors/therapeutic use ; Mutation ; Genotype ; Drug Resistance, Viral/genetics ; Prevalence ; Sequence Analysis
Czasopismo naukowe
Tytuł:
HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.
Autorzy:
Togna Pabo WLR; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon.; Faculty of Science, University of Buea, Buea, Cameroon.
Fokam J; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon.; Faculty of Health Sciences, University of Buea, Buea, Cameroon.; National HIV Drug Resistance Group, Ministry of Public Health, Yaoundé, Cameroon.
Njume D; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon.; Faculty of Health Sciences, University of Buea, Buea, Cameroon.
Takou D; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
Santoro MM; University of Rome Tor Vergata, Rome, Italy.
Nyasa RB; Faculty of Science, University of Buea, Buea, Cameroon.
Chenwi C; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon.
Mpouel ML; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon.
Beloumou G; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
Jagni ESN; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; University of Rome Tor Vergata, Rome, Italy.; Evangelic University of Cameroon, Bandjoun, Cameroon.
Nka AD; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; University of Rome Tor Vergata, Rome, Italy.; Evangelic University of Cameroon, Bandjoun, Cameroon.
Ka'e AC; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; University of Rome Tor Vergata, Rome, Italy.
Teto G; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
Dambaya B; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
Djupsa S; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
Gouissi Anguechia DH; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon.
Evariste M; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
Kamta C; Mfou District Hospital, Mfou, Cameroon.
Bala L; Mbalmayo District Hospital, Mbalmayo, Cameroon.
Lambo V; Nkomo Integrated Health Center, Nkomo, Cameroon.
Halle-Ekane EG; Faculty of Health Sciences, University of Buea, Buea, Cameroon.
Colizzi V; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; University of Rome Tor Vergata, Rome, Italy.; Evangelic University of Cameroon, Bandjoun, Cameroon.
Perno CF; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; University of Rome Tor Vergata, Rome, Italy.; Bambino Gesu Pediatric Hospital, Rome, Italy.
Ndjolo A; Chantal BIYA International Reference Centre for Research on HIV/AIDS prevention and management, Yaoundé, Cameroon.; Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon.
Ndip Ndip R; Faculty of Science, University of Buea, Buea, Cameroon.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Oct 25; Vol. 18 (10), pp. e0293326. Date of Electronic Publication: 2023 Oct 25 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
HIV Infections*/drug therapy
HIV Seropositivity*/drug therapy
Humans ; Male ; Female ; Adolescent ; Cohort Studies ; Cameroon/epidemiology ; Drug Resistance, Viral/genetics ; Viral Load
Czasopismo naukowe
Tytuł:
HIV-1 drug resistance and genetic transmission network among newly diagnosed people living with HIV/AIDS in Ningbo, China between 2018 and 2021.
Autorzy:
Hong H; School of Public health, Health Science Center, Ningbo University, Ningbo, Zhengjiang, 315211, China.
Tang C; School of Public health, Health Science Center, Ningbo University, Ningbo, Zhengjiang, 315211, China.
Liu Y; Ningbo Center for Disease Control and Prevention, Ningbo, Zhengjiang, 315010, China.
Jiang H; Ningbo Center for Disease Control and Prevention, Ningbo, Zhengjiang, 315010, China.
Fang T; School of Public health, Health Science Center, Ningbo University, Ningbo, Zhengjiang, 315211, China.
Xu G; School of Public health, Health Science Center, Ningbo University, Ningbo, Zhengjiang, 315211, China. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2023 Oct 13; Vol. 20 (1), pp. 233. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Acquired Immunodeficiency Syndrome*
HIV-1*/genetics
HIV Infections*/epidemiology
HIV Seropositivity*
Humans ; Middle Aged ; Cross-Sectional Studies ; Phylogeny ; Genotype ; China/epidemiology ; Drug Resistance, Viral/genetics
Czasopismo naukowe
Tytuł:
HIV Drug Resistance Patterns and Characteristics Associated with Clinically Significant Drug Resistance among Children with Virologic Failure on Antiretroviral Treatment in Kenya: Findings from the Opt4Kids Randomized Controlled Trial.
Autorzy:
Abuogi L; Department of Pediatrics, University of Colorado, Denver, CO 80045, USA.
Oyaro P; Health Innovations Kenya (HIK), Kisumu 40100, Kenya.; United States Agency for International Development, Washington, DC 20004, USA.
Wakjira G; Department of Medicine, University of Washington, Seattle, WA 98195, USA.
Thomas KK; Department of Global Health, University of Washington, Seattle, WA 98105, USA.
Scallon AJ; Department of Global Health, University of Washington, Seattle, WA 98105, USA.
Mukui I; Drugs for Neglected Diseases Initiative (DNDI), Nairobi 21936, Kenya.
Chohan BH; Department of Global Health, University of Washington, Seattle, WA 98105, USA.; Kenya Medical Research Institute, Nairobi 00200, Kenya.
Brown E; UWKenya, Nairobi 00200, Kenya.
Karauki E; UWKenya, Nairobi 00200, Kenya.
Yongo N; UWKenya, Nairobi 00200, Kenya.
Ahmed B; Department of Pediatrics, University of Colorado, Denver, CO 80045, USA.
Hassan SA; Department of Medicine, University of Washington, Seattle, WA 98195, USA.
Wagude J; Department of Health, Ministry of Health, Siaya 40600, Kenya.
Kinywa E; Department of Health, Ministry of Health, Kisumu 40100, Kenya.
Otieno L; Family AIDS Care and Education Services, Kenya Medical Research Institute, Kisumu 40100, Kenya.
Kingwara L; National HIV Reference Laboratory, Kenya Ministry of Health, Nairobi 00202, Kenya.
Oyaro B; Kenya Medical Research Institute-CDC, Kisumu 40100, Kenya.
Frenkel LM; Department of Medicine, University of Washington, Seattle, WA 98195, USA.; Department of Global Health, University of Washington, Seattle, WA 98105, USA.; Departments of Pediatrics, University of Washington, Seattle, WA 98195, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
John-Stewart G; Department of Medicine, University of Washington, Seattle, WA 98195, USA.; Department of Global Health, University of Washington, Seattle, WA 98105, USA.; Departments of Pediatrics, University of Washington, Seattle, WA 98195, USA.
Patel RC; Department of Medicine, University of Washington, Seattle, WA 98195, USA.; Department of Global Health, University of Washington, Seattle, WA 98105, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Oct 12; Vol. 15 (10). Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/drug therapy
HIV-1*/genetics
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
Humans ; Child ; Female ; Male ; Kenya ; Treatment Failure ; Drug Resistance, Viral/genetics ; Anti-Retroviral Agents/therapeutic use ; Viral Load
Czasopismo naukowe
Tytuł:
HIV-1 Resistance to Islatravir/Tenofovir Combination Therapy in Wild-Type or NRTI-Resistant Strains of Diverse HIV-1 Subtypes.
Autorzy:
Cilento ME; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Wen X; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Reeve AB; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
Ukah OB; CS Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, USA.
Snyder AA; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Carrillo CM; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Smith CP; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Edwards K; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Wahoski CC; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Kitzler DR; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Kodama EN; Division of Infectious Disease, International Institute of Disaster Science, Tohoku University, Sendai 980-8572, Japan.
Mitsuya H; Department of Refractory Viral Infections, National Center for Global Health & Medicine Research Institute, Tokyo 162-8655, Japan.; Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Department of Clinical Sciences, Kumamoto University Hospital, Kumamoto 860-8556, Japan.
Parniak MA; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
Tedbury PR; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Sarafianos SG; Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Sep 25; Vol. 15 (10). Date of Electronic Publication: 2023 Sep 25.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*/genetics
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Humans ; Tenofovir/pharmacology ; Tenofovir/therapeutic use ; Reverse Transcriptase Inhibitors/pharmacology ; Reverse Transcriptase Inhibitors/therapeutic use ; Drug Resistance, Viral/genetics ; Mutation
Czasopismo naukowe
Tytuł:
Recommendations on data sharing in HIV drug resistance research.
Autorzy:
Inzaule SC; Amsterdam Institute for Global Health and Development, and Department of Global Health, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Siedner MJ; Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
Little SJ; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, California, United States of America.
Avila-Rios S; Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Ayitewala A; National Health Laboratories and Diagnostic Services, Ministries of Health, Kampala, Uganda.
Bosch RJ; Center for Biostatistics in AIDS Research, Harvard TH Chan School of Public Health, Boston, Massachusetts, United States of America.
Calvez V; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.
Ceccherini-Silberstein F; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
Charpentier C; Service de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, F-75018 Paris, France.
Descamps D; Service de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, F-75018 Paris, France.
Eshleman SH; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Fokam J; Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon, and Faculty of Health Sciences, University of Buea, Yaoundé, Cameroon.
Frenkel LM; Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.
Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, United Kingdom.
Ioannidis JPA; Department of Medicine, Department of Epidemiology and Population Health, and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, United States of America.
Kaleebu P; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, Entebbe, Uganda.
Kantor R; Department of Medicine, Brown University, The Miriam Hospital, Providence, Rhode Island, United States of America.
Kassaye SG; Department of Medicine, Division of Infectious Diseases, Georgetown University, Washington DC, United States of America.
Kosakovsky Pond SL; Institute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.
Kouamou V; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Kouyos RD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland and Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Kuritzkes DR; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Lessells R; Affiliation is KwaZulu-Natal Research Innovation & Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa.
Marcelin AG; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, Paris, France.
Mbuagbaw L; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
Minalga B; Office of HIV/AIDS Network Coordination, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Ndembi N; Institute of Human Virology Nigeria, Herbert Macaulay Way, Abuja, Nigeria.
Neher RA; Biozentrum, University of Basel, Basel, Switzerland.
Paredes R; Department of Infectious Diseases & irsiCaixa, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain.
Pillay D; Division of Infection and Immunity, University College London, London, United Kingdom.
Raizes EG; United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Rhee SY; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California, United States of America.
Richman DD; Center for AIDS Research, Department of Medicine, University of California San Diego, San Diego, California, United States of America.
Ruxrungtham K; School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Sabeti PC; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Schapiro JM; National Hemophilia Center, Sheba Medical Center, Ramat Gan, Israel.
Sirivichayakul S; Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Steegen K; Department of Molecular Medicine and Haematology, National Health Laboratory Service, Johannesburg, South Africa.
Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
van Zyl GU; Division of Medical Virology, Stellenbosch University and National Health Laboratory Service, Cape Town, South Africa.
Vandamme AM; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium.; Center for Global Health And Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
Wensing AMJ; University Medical Center Utrecht, the Netherlands and Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.
Wertheim JO; Department of Medicine, University of California San Diego, San Diego, La Jolla, California, United States of America.
Gunthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland and Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Jordan MR; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
Shafer RW; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California, United States of America.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2023 Sep 22; Vol. 20 (9), pp. e1004293. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV-1*/genetics
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
Humans ; Phylogeny ; Drug Resistance, Viral/genetics ; Anti-Retroviral Agents/therapeutic use ; Mutation
Czasopismo naukowe
Tytuł:
Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance.
Autorzy:
Botha JC; Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.; Advanced Pathogen Diagnostics Unit, University College London Hospitals NHS Trust, London NW1 2PG, UK.
Byott M; Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.; Advanced Pathogen Diagnostics Unit, University College London Hospitals NHS Trust, London NW1 2PG, UK.
Spyer MJ; Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.; Advanced Pathogen Diagnostics Unit, University College London Hospitals NHS Trust, London NW1 2PG, UK.
Grant PR; Health Services Laboratories, London WC1H 9AX, UK.
Gärtner K; Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
Chen WX; ViiV Healthcare, Durham, NC 27709, USA.
Burton J; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
Bamford A; Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.; Medical Research Council Clinical Trials Unit, University College London, London WC1E 6BT, UK.
Waters LJ; Central and North West London NHS Foundation Trust, Mortimer Market, London WC1E 6JB, UK.
Giaquinto C; Department of Women and Child Health, University of Padova, 35122 Padova, Italy.; Fondazione Penta ETS, 35127 Padova, Italy.
Turkova A; Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.; Medical Research Council Clinical Trials Unit, University College London, London WC1E 6BT, UK.
Vavro CL; ViiV Healthcare, Durham, NC 27709, USA.
Nastouli E; Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.; Advanced Pathogen Diagnostics Unit, University College London Hospitals NHS Trust, London NW1 2PG, UK.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Aug 25; Vol. 15 (9). Date of Electronic Publication: 2023 Aug 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV-1*/genetics
HIV Infections*/drug therapy
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Seropositivity*
Humans ; Genotype ; Drug Resistance, Viral/genetics ; Anti-Retroviral Agents/therapeutic use ; Mutation ; High-Throughput Nucleotide Sequencing
Czasopismo naukowe
Tytuł:
HIV-1 molecular transmission network and drug resistance in Chongqing, China, among men who have sex with men (2018-2021).
Autorzy:
Tan T; Chongqing Center for Disease Control and Prevention, 400042, Chongqing, China.
Bai C; Chongqing Center for Disease Control and Prevention, 400042, Chongqing, China.
Lu R; Chongqing Center for Disease Control and Prevention, 400042, Chongqing, China.
Chen F; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Li L; Chongqing Center for Disease Control and Prevention, 400042, Chongqing, China.
Zhou C; Chongqing Center for Disease Control and Prevention, 400042, Chongqing, China.
Xiang X; Chongqing Center for Disease Control and Prevention, 400042, Chongqing, China.
Zhang W; Chongqing Center for Disease Control and Prevention, 400042, Chongqing, China.
Ouyang L; Chongqing Center for Disease Control and Prevention, 400042, Chongqing, China.
Xu J; Chongqing Center for Disease Control and Prevention, 400042, Chongqing, China.
Tang H; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. .
Wu G; Chongqing Center for Disease Control and Prevention, 400042, Chongqing, China. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2023 Jul 13; Vol. 20 (1), pp. 147. Date of Electronic Publication: 2023 Jul 13.
Typ publikacji:
Journal Article
MeSH Terms:
HIV-1*
Sexual and Gender Minorities*
HIV Seropositivity*/genetics
HIV Infections*/epidemiology
Humans ; Male ; Female ; Homosexuality, Male ; Phylogeny ; Drug Resistance, Viral/genetics ; China/epidemiology ; Genotype
Czasopismo naukowe
Tytuł:
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens.
Autorzy:
Fokam J; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.; Faculty of Health Science, University of Buea, Buea P.O. Box 0063, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.; National HIV Drug Resistance Prevention and Surveillance Working Group, Ministry of Public Health, Yaoundé P.O. Box 3038, Cameroon.
Chenwi CA; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Via Montpellier 1, 00133 Rome, Italy.
Tala V; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.
Takou D; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.
Santoro MM; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Via Montpellier 1, 00133 Rome, Italy.
Teto G; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.
Dambaya B; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.
Anubodem F; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.
Semengue ENJ; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Via Montpellier 1, 00133 Rome, Italy.; Faculty of Sciences and Technologies, Evangelical University of Cameroon, Bandjoun P.O. Box 0127, Cameroon.
Beloumou G; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.
Djupsa S; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.
Assomo E; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.
Fokunang C; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.
Alteri C; Department of Oncology and Hemato-Oncology, University of Milan, Via Festa del Perdono 7, 20122 Milano, Italy.
Billong S; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.; National HIV Drug Resistance Prevention and Surveillance Working Group, Ministry of Public Health, Yaoundé P.O. Box 3038, Cameroon.
Bouba NP; Department of Disease, Epidemic and Pandemic Control, Ministry of Public Health, Yaounde P.O. Box 3038, Cameroon.
Ajeh R; Central Technical Group, National AIDS Control Committee, Yaoundé P.O. Box 2005, Cameroon.
Colizzi V; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Via Montpellier 1, 00133 Rome, Italy.; Faculty of Sciences and Technologies, Evangelical University of Cameroon, Bandjoun P.O. Box 0127, Cameroon.
Mbanya D; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.; National Blood Transfusion Service, Ministry of Public Health, Yaoundé P.O. Box 3038, Cameroon.; Haematology and Transfusion Service, Centre Hospitalier et Universitaire (CHU), Yaoundé P.O. Box 30335, Cameroon.
Ceccherini-Silberstein F; Department of Experimental Medicine, Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Via Montpellier 1, 00133 Rome, Italy.
Perno CF; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.; Bambino Gesu' Children's Research Hospital, Piazza S. Onofrio 4, 00165 Rome, Italy.
Ndjolo A; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Messa, Yaoundé P.O. Box 3077, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 1364, Cameroon.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jun 28; Vol. 15 (7). Date of Electronic Publication: 2023 Jun 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV-1*/genetics
Humans ; Female ; Adult ; Middle Aged ; Male ; Cameroon/epidemiology ; Anti-Retroviral Agents/therapeutic use ; Genetic Variation ; Drug Resistance, Viral/genetics
Czasopismo naukowe
Tytuł:
Optimizing Antiretroviral Therapy in Heavily ART-Experienced Patients with Multi-Class Resistant HIV-1 Using Proviral DNA Genotypic Resistance Testing.
Autorzy:
Rauschning D; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Department Ib of Internal Medicine, Bundeswehrzentralkrankenhaus Koblenz, Rübenacher Straße 170, 56072 Koblenz, Germany.
Ehren I; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
Heger E; Institute of Virology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Fürst-Pückler-Straße 56, 50935 Cologne, Germany.
Knops E; Institute of Virology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Fürst-Pückler-Straße 56, 50935 Cologne, Germany.
Fätkenheuer G; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
Suárez I; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Partner Site Bonn-Cologne, German Center for Infection Research (DZIF), 38124 Braunschweig, Germany.
Lehmann C; Division of Infectious Diseases, Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Medical Faculty and University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.; Partner Site Bonn-Cologne, German Center for Infection Research (DZIF), 38124 Braunschweig, Germany.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Jun 27; Vol. 15 (7). Date of Electronic Publication: 2023 Jun 27.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/drug therapy
HIV-1*/genetics
HIV Seropositivity*
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
Humans ; Proviruses/genetics ; Retrospective Studies ; Genotype ; Anti-Retroviral Agents/pharmacology ; Anti-Retroviral Agents/therapeutic use ; DNA, Viral/genetics ; RNA, Viral/genetics ; Viral Load ; Drug Resistance, Viral/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies